NSE · SMSPHARMA.NS
SMS Pharmaceuticals Limited
₹514.60+₹28.80 (+5.93%)
SMS Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 1.98% below the high.
Loading market information…
BSE · SYSCHEM.BO · INR
Stock price, earnings
Quote as of Oct 30, 2026, 05:56 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Syschem (India) Limited’s quoted price sits in the lower half of its reported 52-week range, 44.38% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Syschem (India) Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Syschem India Limited is a company focused on manufacturing active pharmaceutical ingredients (APIs), chemical intermediates, and specialized chemical products. Its offerings include a range of antibiotics like amoxicillin tri hydrate, ampicillin tri hydrate, cloxacillin sodium, dicloxacillin sodium, flucloxacillin sodium, oxacillin, and cephalexin. The firm began operations on December 31, 1993, and its main office is located in Chandigarh, India.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:29 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹514.60+₹28.80 (+5.93%)
SMS Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 1.98% below the high.
₹215.68+₹11.28 (+5.52%)
Hikal Limited’s quoted price sits in the upper half of its reported 52-week range, 17.36% below the high.
₹86.89+₹7.15 (+8.97%)
Anuh Pharma Limited’s quoted price sits in the upper half of its reported 52-week range, 12.67% below the high.
₹281.00+₹3.00 (+1.08%)
Infinium Pharmachem Ltd.’s quoted price sits in the upper half of its reported 52-week range, 13.41% below the high.
₹109.00-₹1.84 (-1.66%)
Aarey Drugs & Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 5.05% below the high.
₹10.30-₹0.03 (-0.29%)
Nectar Lifesciences Limited’s quoted price sits in the lower half of its reported 52-week range, 54.02% below the high.
₹47.98+₹0.12 (+0.25%)
Oxygenta Pharmaceutical Ltd.’s quoted price sits in the lower half of its reported 52-week range, 32.98% below the high.
₹114.67-₹6.03 (-5.0%)
Par Drugs and Chemicals Limited’s quoted price sits in the lower half of its reported 52-week range, 36.29% below the high.
